Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. - Gregg LP; Richardson PA; Nambi V; Petersen LA; Matheny ME; Virani SS; Navaneethan SD (Journal of the American Society of Nephrology : JASN, 2025)